FEATURED SOLUTIONS

• Lead Optimization In Drug Discovery

  Altasciences specializes in lead optimization studies, helping you identify the most promising drug candidates through precise, data-driven preclinical screening. Our expert scientists tailor each study to your unique needs, utilizing efficient non-GLP screening protocols to accelerate decision-making. With streamlined study designs, clear data visualization, and rapid turnaround times, we provide actionable insights to advance your drug discovery pipeline.

• Cell And Gene Therapy Development From Altasciences

  With over 130 in-life gene therapy studies completed, Altasciences is a leading expert in gene therapy research, with integrated preclinical and bioanalytical capabilities.

• Altasciences' Commitment To Animal Welfare

  We maintain an unwavering focus on the welfare of the laboratory animals in our care. Our entire preclinical staff is trained in laboratory animal care and focused on animal welfare and environmental enrichment — embracing compassion, sensitivity and adherence to regulatory guidelines.

• Immunotoxicology/Immunology

  Preclinical immunotoxicology studies play a crucial role in assessing the potential adverse effects of drugs, chemicals, or other substances on the immune system before they advance to first-in-human linical trials.

• Preclinical Safety Pharmacology Studies

  Safety pharmacology is the cornerstone of responsible drug development. It involves the evaluation of a drug candidate's potential impact on vital organ systems such as the cardiovascular, respiratory, and central nervous systems. By identifying any potential safety concerns early in the development process, safety pharmacology studies play a crucial role in minimizing risks to patients and ensuring the overall safety and efficacy of the final product.

• Pivotal Toxicology Studies

  Leveraging extensive expertise and state-of-the-art facilities, Altasciences conducts comprehensive toxicology evaluations to ensure the safety and regulatory compliance of your novel drug candidates.

• Miniature Swine In Nonclinical Studies

  The miniature swine continues to develop as a viable non-rodent option for nonclinical studies. With the increase of historical data and wider regulatory acceptance, the miniature swine model can support a variety of research areas. Their availability, physiological similarities to humans, and lower cost compared to other non-rodent models makes miniature pigs an advantageous option for nonclinical programs. However, it is essential that scientific rationale is the driving factor when selecting species for your study.

• Altasciences' Award-Winning Preclinical Research Services

  Industry leader in preclinical safety assessments across various therapeutic areas. 30+ years of experience in full range of in vivo non-GLP and GLP studies in both rodent and non-rodent species.

• Altasciences' Preclinical Services

  Partner with us to accelerate your drug development journey, from lead candidate selection to proof of concept, with our comprehensive, globally compliant preclinical, clinical, and manufacturing solutions.

• Miniature Swine

  Species selection for preclinical studies should be based on solid scientific rationale. Our experts will assess all available data to guide you in making a well-informed, appropriate choice.